Canada markets closed

Ligand Pharmaceuticals Incorporated (LGND)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
86.40+1.49 (+1.75%)
At close: 04:00PM EDT
84.91 -1.49 (-1.72%)
After hours: 04:31PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts4443
Avg. Estimate0.991.174.645.54
Low Estimate0.941.074.55.29
High Estimate1.031.264.725.84
Year Ago EPS1.421.026.094.64
Revenue EstimateCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts5554
Avg. Estimate31.9M35.85M137.79M160.6M
Low Estimate30.5M33.31M134M153.8M
High Estimate33.56M38M141.3M170M
Year Ago SalesN/AN/A131.31M137.79M
Sales Growth (year/est)N/AN/A4.90%16.60%
Earnings History2023-06-292023-09-292023-12-302024-03-30
EPS Est.0.640.610.660.78
EPS Actual1.421.021.381.2
Difference0.780.410.720.42
Surprise %121.90%67.20%109.10%53.80%
EPS TrendCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Current Estimate0.991.174.645.54
7 Days Ago0.991.174.645.54
30 Days Ago1.031.214.445.6
60 Days Ago1.021.194.455.6
90 Days Ago0.941.164.275.35
EPS RevisionsCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days2251
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesLGNDIndustrySector(s)S&P 500
Current Qtr.-30.30%N/AN/AN/A
Next Qtr.14.70%N/AN/AN/A
Current Year-23.80%N/AN/AN/A
Next Year19.40%N/AN/AN/A
Next 5 Years (per annum)20.00%N/AN/AN/A
Past 5 Years (per annum)12.40%N/AN/AN/A